Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oftipan
- Development stage
- Unknown
- Lead developer
- Jelfa
- Administration
- Ophthalmic
01
Overview
Oftipan is an over-the-counter artificial tears ophthalmic lubricant product marketed by Valeant Pharmaceuticals/Bausch & Lomb for relief of dry eye symptoms and ocular surface irritation. It is a non‑pharmaceutical eye lubricant preparation containing inert moisturizing and protective agents designed to stabilize the tear film, reduce friction between the eyelid and cornea, and protect the ocular surface without exerting any specific pharmacologic action on ocular tissues. As an artificial tears formulation, its components act locally on the eye surface and are not intended to modify disease biology systemically.
- Brand names
- Oftipan
Beyond the preview
Go deeper on Oftipan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oftipan.